- Home
- BOKF vs HALO Comparison
BOKF vs HALO Comparison
Compare BOKF & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOKF
- HALO
- Stock Information
- Founded
- BOKF 1910
- HALO 1998
- Country
- BOKF United States
- HALO United States
- Employees
- BOKF N/A
- HALO N/A
- Industry
- BOKF Major Banks
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOKF Finance
- HALO Health Care
- Exchange
- BOKF Nasdaq
- HALO Nasdaq
- Market Cap
- BOKF 6.0B
- HALO 7.4B
- IPO Year
- BOKF N/A
- HALO N/A
- Fundamental
- Price
- BOKF $104.77
- HALO $57.65
- Analyst Decision
- BOKF Hold
- HALO Buy
- Analyst Count
- BOKF 11
- HALO 9
- Target Price
- BOKF $111.55
- HALO $63.56
- AVG Volume (30 Days)
- BOKF 230.9K
- HALO 2.9M
- Earning Date
- BOKF 07-21-2025
- HALO 08-05-2025
- Dividend Yield
- BOKF 2.19%
- HALO N/A
- EPS Growth
- BOKF 26.68
- HALO 55.40
- EPS
- BOKF 8.72
- HALO 3.76
- Revenue
- BOKF $2,087,418,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- BOKF $5.98
- HALO $25.77
- Revenue Next Year
- BOKF $7.47
- HALO $18.01
- P/E Ratio
- BOKF $11.95
- HALO $15.34
- Revenue Growth
- BOKF 7.09
- HALO 25.64
- 52 Week Low
- BOKF $85.08
- HALO $42.01
- 52 Week High
- BOKF $121.58
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- BOKF 68.91
- HALO 64.22
- Support Level
- BOKF $101.26
- HALO $51.06
- Resistance Level
- BOKF $105.32
- HALO $57.97
- Average True Range (ATR)
- BOKF 2.36
- HALO 1.37
- MACD
- BOKF 0.65
- HALO 0.66
- Stochastic Oscillator
- BOKF 95.16
- HALO 93.08
About BOKF BOK Financial Corporation
BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.